Skip to main content

Site notifications

Notice for selpercatinib (Eli Lilly Australia Pty Ltd)

Active ingredients
selpercatinib
Date of review outcome
Lapse date
Type
Provisional determination
Therapeutic area
Oncology

Help us improve this page